| Heart Failure (HF) |
1 |
1 |
| Heart |
0 |
0.96 |
| Cardiovascular Risk Management |
0 |
0.79 |
| Coronary Artery Disease (CAD) |
0 |
0.76 |
| Preventive Screening |
0 |
0.18 |
| Medical Life |
0 |
0.09 |
| B-Type Natriuretic Peptide |
0 |
0.06 |
| Biomarker |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.06 |
| Geriatrics |
0 |
0.06 |
| Lung |
0 |
0.06 |
| Match |
0 |
0.06 |
| Plasma |
0 |
0.06 |
| SGLT2 Inhibitor |
0 |
0.06 |
| Socioeconomics |
0 |
0.06 |
| Troponin |
0 |
0.06 |
| Type 2 Diabetes Mellitus |
0 |
0.99 |